Blood:gas partition coefficient

Core concept → what it predicts at the bedside

  • The blood:gas partition coefficient (λB:G) is the key determinant of how quickly alveolar partial pressure (FA) rises towards inspired partial pressure (FI), and therefore how quickly the brain partial pressure rises.
    • Lower λB:G → less uptake into blood for a given alveolar partial pressure → faster rise in FA/FI → faster induction and faster recovery (all else equal).
    • Higher λB:G → more uptake into blood → slower rise in FA/FI → slower induction and slower recovery.
  • λB:G does not measure potency (that is MAC); it measures solubility in blood relative to gas, which influences kinetics.

Clinical implications you can state in a viva

  • Low λB:G agents (e.g. desflurane, sevoflurane, nitrous oxide) give rapid changes in depth and rapid wake-up; high λB:G agents (e.g. isoflurane, halothane) change more slowly.
  • When λB:G is high, factors that increase uptake (high cardiac output, high alveolar–venous partial pressure gradient) have a larger slowing effect on FA/FI.
  • In low λB:G agents, the system is less uptake-limited; changes in ventilation and delivered concentration translate to faster changes in FA.

Definition and interpretation

  • Blood:gas partition coefficient (λB:G) = ratio of concentration of anaesthetic in blood to that in alveolar gas when partial pressures are equal at equilibrium.
    • It is a solubility ratio: how much dissolves in blood compared with remaining in gas phase at the same partial pressure.
    • Units: dimensionless.
  • A practical way to phrase it: λB:G tells you how big the ‘blood reservoir’ is for a given alveolar partial pressure.

Typical values (approximate; order matters more than exact numbers)

  • Desflurane: ~0.42
  • Nitrous oxide: ~0.47
  • Sevoflurane: ~0.65
  • Isoflurane: ~1.4
  • Halothane: ~2.4

Link to FA/FI and uptake (the standard FRCA explanation)

  • Rate of rise of FA/FI is slowed by uptake of agent from alveoli into blood.
  • Uptake is increased by: higher λB:G, higher cardiac output, higher alveolar–venous partial pressure gradient, and higher inspired concentration (concentration effect).
    • High λB:G increases the amount taken up for a given alveolar partial pressure, so FA rises more slowly.
  • Ventilation: increasing alveolar ventilation increases delivery of agent to alveoli and tends to increase FA/FI; this effect is more pronounced for soluble agents (high λB:G) because uptake would otherwise keep FA low.

Determinants of λB:G (what changes it?)

  • λB:G depends on solubility in whole blood: plasma solubility + red cell solubility (including binding to proteins/lipids).
  • Temperature: increasing temperature generally decreases solubility of gases in liquids → lowers λB:G → faster FA rise (small effect clinically).
  • Haematocrit: can alter blood solubility depending on agent’s affinity for RBCs; effect is agent-dependent and usually modest clinically.
  • Plasma proteins/lipids: increased lipid content can increase solubility for lipophilic agents; major clinical relevance is limited compared with cardiac output/ventilation effects.

Clinical scenarios: how λB:G interacts with physiology

  • High cardiac output (e.g. sepsis, pregnancy, anxiety/pain): increases uptake from alveoli → slows FA/FI rise, especially for high λB:G agents; may need higher delivered concentration to achieve target FA.
  • Low cardiac output (e.g. shock): reduces uptake → FA rises faster (risk of rapid deepening); but tissue perfusion is reduced so equilibration to brain may be less predictable.
  • Hyperventilation: speeds induction more for soluble agents; less impact for poorly soluble agents where FA already rises quickly.
  • Recovery: low λB:G → less blood and tissue storage → faster washout; high λB:G → more storage and slower washout (particularly after long cases due to tissue compartments).

Distinguish from other partition coefficients

  • Oil:gas partition coefficient correlates with potency (MAC) via Meyer–Overton; not with speed of onset.
  • Brain:blood (or vessel-rich group:blood) partition influences how much agent is required to saturate brain tissue, but λB:G remains the key driver of FA rise and early kinetics.
Define the blood:gas partition coefficient and explain its clinical significance.

Aim: definition + link to FA/FI + induction/recovery.

  • λB:G is the ratio of concentration in blood to concentration in alveolar gas when partial pressures are equal at equilibrium.
  • It reflects blood solubility: higher λB:G means more dissolves in blood for a given alveolar partial pressure.
  • High λB:G increases uptake from alveoli → slows rise of FA/FIslower induction and slower recovery.
  • Low λB:G → minimal blood reservoir → FA rises quickly → rapid changes in depth and rapid wake-up.
Rank common volatile agents by blood:gas solubility and relate this to speed of induction.

You can score well by giving the correct order and a brief consequence.

  • Lowest to highest λB:G (typical): desflurane (~0.42) ≈ nitrous oxide (~0.47) < sevoflurane (~0.65) < isoflurane (~1.4) < halothane (~2.4).
  • Lower λB:G agents have faster FA/FI rise → faster induction and emergence.
Explain why increasing cardiac output slows induction more with isoflurane than with desflurane.

This is a classic uptake/solubility interaction question.

  • Higher cardiac output increases pulmonary blood flow, increasing uptake of anaesthetic from alveoli into blood.
  • With a higher λB:G agent (isoflurane), blood can dissolve more agent at a given alveolar partial pressure, so increased flow removes proportionally more agent from alveoli, keeping FA lower and slowing FA/FI rise.
  • With a low λB:G agent (desflurane), blood takes up relatively little at a given partial pressure, so the effect of increased flow on FA is smaller.
How does hyperventilation affect the rate of rise of FA/FI for soluble versus insoluble agents?

Expect to compare high vs low λB:G.

  • Increasing alveolar ventilation increases delivery of agent to alveoli and tends to increase FA/FI.
  • Effect is greater for soluble (high λB:G) agents because uptake would otherwise keep FA low; extra ventilation helps ‘keep up’ with uptake.
  • Effect is smaller for insoluble (low λB:G) agents because FA rises quickly even without large changes in ventilation.
A previous-style question: ‘What factors determine the rate of rise of alveolar concentration of an inhalational agent?’ Where does blood:gas partition coefficient fit?

Structure your answer as delivery vs uptake.

  • Delivery to alveoli: inspired concentration (vaporiser setting), fresh gas flow/circuit factors, and alveolar ventilation.
  • Uptake from alveoli: blood:gas partition coefficient, cardiac output, and alveolar–venous partial pressure gradient.
  • λB:G increases uptake for a given FA, slowing the rise of FA/FI and delaying equilibration with brain.
Explain why low blood:gas solubility leads to faster recovery, and when this advantage may be reduced.

Mention tissue storage and duration of anaesthesia.

  • Low λB:G means less agent is dissolved in blood at a given partial pressure, so there is less to wash out when you turn the vaporiser off.
  • This produces a faster fall in FA and therefore faster fall in brain partial pressure (faster emergence).
  • Advantage may be reduced after prolonged cases due to accumulation in tissue compartments (especially fat), and by low alveolar ventilation post-op (hypoventilation).
Differentiate blood:gas partition coefficient from oil:gas partition coefficient.

A common FRCA viva discriminator.

  • Blood:gas partition coefficient reflects solubility in blood and predicts speed of onset/offset (kinetics).
  • Oil:gas partition coefficient reflects lipid solubility and correlates with potency (lower MAC) via Meyer–Overton.
What patient factors can alter blood:gas partition coefficient and do they matter clinically?

Be honest: many effects are small; physiology often dominates.

  • Temperature: increased temperature decreases solubility → lowers λB:G (modest clinical effect).
  • Haematocrit: may change solubility depending on RBC affinity; usually modest effect compared with cardiac output/ventilation.
  • Plasma proteins/lipids: increased lipid content may increase solubility for lipophilic agents; limited routine impact.
Past-style calculation/interpretation: ‘If an agent has a blood:gas partition coefficient of 2.0, what does that mean at equilibrium?’

They want the ratio interpretation at equal partial pressure.

  • At equilibrium with equal partial pressures in blood and alveolar gas, the concentration in blood is 2 times the concentration in alveolar gas.
  • This implies relatively high blood solubility and therefore greater uptake and slower FA/FI rise compared with an agent with λB:G < 1.
How would you explain to an examiner why nitrous oxide has a low blood:gas coefficient but is not always ‘fast’ in practice?

This tests that you can separate solubility from other practical constraints.

  • Low λB:G supports rapid FA rise, but achievable anaesthetic depth is limited by potency (high MAC ~105%), so it cannot produce surgical anaesthesia alone at 1 atm.
  • Speed of achieving a clinical endpoint also depends on delivered concentration, circuit dynamics, ventilation, and concomitant agents.

0 comments